欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/4690/001
药品名称	Delmuno 2,5/2,5 mg
活性成分	Felodipine 2.5 mg Ramipril 2.5 mg
剂型	Prolonged-release tablet
上市许可持有人	Sanofi-Aventis Deutschland GmbH Brüningstrasse 50 65926 Frankfurt am Main Germany
参考成员国 - 产品名称	Germany (DE) Delmuno 2,5/2,5 mg
互认成员国 - 产品名称	Ireland (IE) Portugal (PT)
许可日期	2008/04/05
最近更新日期	2025/01/28
药物ATC编码	C09BB05 ramipril and felodipine
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final Product Information \| common_final_pl_4690_V060Date of last change:2024/09/06 Final Product Information \| common_final_spc_4690_V060Date of last change:2024/09/06 Final Labelling \| common_interpack_ramipril_felodipine25and5_annotated_May 2021Date of last change:2024/09/06 Final Labelling \| common_interpack_ramipril_felodipine25and5_clean_May 2021Date of last change:2024/09/06 Final PL \| RAMIPRIL_FELODIPINE_annotated_ common pil_Mar 2021Date of last change:2024/09/06 Final SPC \| RAMIPRIL_FELODIPINE_annotated_common_spc_May 2021Date of last change:2024/09/06 Final PL \| RAMIPRIL_FELODIPINE_clean_ common pil_Mar 2021Date of last change:2024/09/06 Final SPC \| RAMIPRIL_FELODIPINE_clean_common_spc_May 2021Date of last change:2024/09/06
市场状态	Positive